| Drug Name |
Nandrolone decanoate |
| Drug ID |
BADD_D01530 |
| Description |
Nandrolone decanoate, also known as nandrolone caprinate, is an alkylated anabolic steroid indicated in the management of anemia of renal insufficiency and as an adjunct therapy in the treatment of senile and postmenopausal osteoporosis.[A233789,A233849,L32564,L9464] The process for creating esters of [nandrolone] was patented in Spain in 1959[L33244] and in 1960, it was described as having a long duration of action and strong anabolic effect compared to nandrolone and other esters.[A233849]
Nandrolone decanoate was granted FDA approval on 5 October 1962.[L32564] |
| Indications and Usage |
For the treatment of refractory deficient red cell production anemias, breast carcinoma, hereditary angioedema, antithrombin III deficiency, fibrinogen excess, growth failure and Turner's syndrome. It is also indicated in the prophylaxis of hereditary angioedema. |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
A14AB01; S01XA11 |
| DrugBank ID |
DB08804
|
| KEGG ID |
D00955
|
| MeSH ID |
D000077603
|
| PubChem ID |
9677
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
51927-0121; 51552-1564; 60870-0233; 62991-2186; 43647-123; 22552-0048; 10695-051; 63275-9889 |
| Synonyms |
Nandrolone Decanoate | 17 beta-Hydroxyestr-4-en-3-one 17-decanoate | 17 beta Hydroxyestr 4 en 3 one 17 decanoate | 19-Nortestosterone Decanoate | 19 Nortestosterone Decanoate | 19-nor-4-Androstene-17 beta-ol-3-one 17-decanoate | 19 nor 4 Androstene 17 beta ol 3 one 17 decanoate | Retabolil | Retabolyl | Decadurabolin | Decadurobolin |
